11/19/2019
1:55 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2019
2:36 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2019
2:41 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2019
1:07 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2019
9:59 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2019
12:59 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
10:33 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
2:13 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
2:53 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
10:14 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
10:41 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
10:55 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2019
11:57 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2019
1:27 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2019
11:19 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
9:53 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
9:27 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
10:42 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2019
10:15 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
3:28 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
11:11 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
9:51 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
11:19 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
11:14 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2019
2:07 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2019
4:20 PM | Nymox Pharmaceutical (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
01/03/2019
12:09 PM | Danielsen Erik (Reporting)
Nymox Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
12:05 PM | Danielsen Erik (Reporting)
Nymox Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2018
2:58 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
9:43 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
9:16 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
9:28 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2018
10:41 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2018
1:09 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
1:34 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
2:43 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
1:29 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2018
2:13 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2018
6:28 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2018
9:56 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
9:51 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
9:43 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
1:50 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2018
4:23 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2018
8:39 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
8:47 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
4:33 PM | Averback Paul (Reporting)
Nymox Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
4:26 PM | Averback Paul (Reporting)
Nymox Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
4:20 PM | LANHAM RANDALL J (Reporting)
Nymox Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
10:36 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
2:46 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
2:17 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
2:11 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2018
10:47 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2018
3:30 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2018
2:10 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2018
4:11 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2018
3:22 PM | Nymox Pharmaceutical (Filer)
| Form 20-F/A
| |
03/30/2018
9:42 AM | Nymox Pharmaceutical (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/27/2018
3:10 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2018
4:55 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
9:49 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2018
1:05 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2018
9:39 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2018
3:20 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2018
10:00 AM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2018
4:29 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2018
2:07 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2018
2:19 PM | Nymox Pharmaceutical (Issuer)
Robinson James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2017
6:04 PM | Nymox Pharmaceutical (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
